• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Hcw Biologics Inc (NQ: HCWB )

    0.4505 +0.0105 (+2.39%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 12,964
    Open 0.4900
    Bid (Size) 0.4772 (10)
    Ask (Size) 0.6000 (13)
    Prev. Close 0.4400
    Today's Range 0.4400 - 0.5499
    52wk Range 0.4000 - 2.140
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga

    Performance

    YTD
    -62.46%
    -62.46%
    1 Month
    +7.26%
    +7.26%
    3 Month
    -27.48%
    -27.48%
    6 Month
    -71.49%
    -71.49%
    1 Year
    -75.65%
    -75.65%

    More News

    Read More
    HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024
    Via InvestorPlace
    HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Looking Into HCW Biologics's Return On Capital Employed
    Via Benzinga
    HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
    From HCW Biologics, Inc
    Via GlobeNewswire
    Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
    From HCW Biologics, Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
    From HCW Biologics, Inc
    Via GlobeNewswire
    Nerdy And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
    Via Benzinga
    $3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    $25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Recap: HCW Biologics Q1 Earnings
    Via Benzinga
    HCW Biologics: Q1 Earnings Insights
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
    From HCW Biologics, Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    HCW Biologics Enters CRADA with National Cancer Institute
    From HCW Biologics, Inc
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.